Ophthalmic sensing technologies for ocular disease diagnostics

Point-of-care diagnosis and personalized treatments are critical in ocular physiology and disease. Continuous sampling of tear fluid for ocular diagnosis is a need for further exploration. Several techniques have been developed for possible ophthalmological applications, from traditional spectroscopies to wearable sensors. Contact lenses are commonly used devices for vision correction, as well as for other therapeutic and cosmetic purposes. They are increasingly being developed into ocular sensors, being used to sense and monitor biochemical analytes in tear fluid, ocular surface temperature, intraocular pressure, and pH value. These sensors have had success in detecting ocular conditions, optimizing pharmaceutical treatments, and tracking treatment efficacy in point-of-care settings. However, there is a paucity of new and effective instrumentation reported in ophthalmology. Hence, this review will summarize the applied ophthalmic technologies for ocular diagnostics and tear monitoring, including both conventional and biosensing technologies. Besides applications of smart readout devices for continuous monitoring, targeted biomarkers are also discussed for the convenience of diagnosis of various ocular diseases. A further discussion is also provided for future aspects and market requirements related to the commercialization of novel types of contact lens sensors

Demonstration of on sky contrast improvement using the Modified Gerchberg-Saxton algorithm at the Palomar Observatory

We have successfully demonstrated significant improvements in the high contrast detection limit of the Well-Corrected Subaperture (WCS) using a number of steps aimed at reducing non-common path (NCP) wavefront errors, including the Autonomous Phase Retrieval Calibration (APRC) software package developed at the Jet Propulsion Laboratory (JPL) for the Palomar adaptive optics instrument (PALAO). APRC utilizes the Modified Gerchberg-Saxton (MGS) wavefront sensing algorithm, also developed at JPL. The WCS delivers such excellent correction of the atmosphere that NCP wavefront errors not sensed by PALAO but present at the coronagraphic image plane begin to factor heavily as a limit to contrast. The APRC program was implemented to reduce these NCP wavefront errors from 110 nm to 35 nm (rms) in the lab, and now these exceptional results have been extended to targets on the sky for the first time, leading to a significant suppression of speckle noise. Consequently we now report a contrast level of very nearly 1×10^(-4) at separations of 2λ/D before the data is post processed, and 1×10^(-5) after post processing. We describe here the major components of our instrument, the work done to improve the NCP wavefront errors, and the ensuing excellent on sky results, including the detection of the three exoplanets orbiting the star HR8799

Ophthalmic sensing technologies for ocular disease diagnostics

Point-of-care diagnosis and personalized treatments are critical in ocular physiology and disease. Continuous sampling of tear fluid for ocular diagnosis is a need for further exploration. Several techniques have been developed for possible ophthalmological applications, from traditional spectroscopies to wearable sensors. Contact lenses are commonly used devices for vision correction, as well as for other therapeutic and cosmetic purposes. They are increasingly being developed into ocular sensors, being used to sense and monitor biochemical analytes in tear fluid, ocular surface temperature, intraocular pressure, and pH value. These sensors have had success in detecting ocular conditions, optimizing pharmaceutical treatments, and tracking treatment efficacy in point-of-care settings. However, there is a paucity of new and effective instrumentation reported in ophthalmology. Hence, this review will summarize the applied ophthalmic technologies for ocular diagnostics and tear monitoring, including both conventional and biosensing technologies. Besides applications of smart readout devices for continuous monitoring, targeted biomarkers are also discussed for the convenience of diagnosis of various ocular diseases. A further discussion is also provided for future aspects and market requirements related to the commercialization of novel types of contact lens sensors